EarliPoint Health

EarliPoint Health is a medical device company making earlier identification and treatment for ASD and related vulnerabilities accessible to children everywhere. Developed by leading researchers at Children’s Healthcare of Atlanta, Emory University School of Medicine and Yale University, EarliTec has pioneered the development of biomarkers that help parents, providers and caregivers understand how a child is viewing the world. The company’s initial product, the EarliPoint™ Evaluation for Autism Spectrum Disorder, is the first objective measurement tool that clinicians can use to assist in the detection and assessment of ASD in children as young as 16 months.  FDA authorized and available for commercial use now!